PAOG SCREAMS BUY - This Cannabis BioTech Could Double By Friday
August 19 2020 - 11:01AM
InvestorsHub NewsWire
August 19, 2020
-- InvestorsHub NewsWire -- via NextBigTicker -- PAO Group, Inc.
(USOTC:
PAOG) is reported today by AmericanBULLS to be “screaming” Buy
(americanbulls.com/PAOG).
“The
green light is on and this security is now
screaming BUY. It is action
time! The bullish pattern that was previously identified is finally
confirmed and a BUY signal is
generated. Most probably, it is the right time to participate in
bullish fervor. Do not miss this bullish
opportunity.”
PAOG climbed
from $0.003 yesterday on high trading volume to $0.005 today as of
this writing. The company is pushing a new 52 week high and
just charted a MACD cross. With the company’s updated
financial statement and OTC Market’s Current Information status
expected as early as by the end of this week, combined with the
overall biotech sector momentum, the PPS could breakout over $0.01
at any moment.
PAOG recently
entered the biotech sector with a proprietary treatment for
respiratory disorders derived from a patented cannabis extract.
The company reports having run a trial of its proprietary
treatment on COVID-19 patients that has compelled the company to
apply for the Coronavirus Treatment Acceleration Program
(CTAP).
Other market movers today include
ARSN,
GAXY and
EWLL.
Disclaimer:
NextBigTicker.com (NBT)is a third party publisher
and news dissemination service provider. NBT is NOT affiliated
in any manner with any company mentioned herein. NBT is news
dissemination solutions provider and are NOT a registered
broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. NBT's
market updates, news alerts and corporate profiles are NOT a
solicitation or recommendation to buy, sell or hold securities. The
material in this release is intended to be strictly informational
and is NEVER to be construed or interpreted as research material.
All readers are strongly urged to perform research and due
diligence on their own and consult a licensed financial
professional before considering any level of investing in
stocks. All material included herein is republished content
and details which were previously disseminated by the companies
mentioned in this release or opinion of the writer. NBT is not
liable for any investment decisions by its readers or subscribers.
Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. NBT has not been
compensated for this release and HOLDS NO SHARES OF ANY
COMPANY NAMED IN THIS
RELEASE.
Disclaimer/Safe
Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur.
Source: www.nextbigticker.com